Previous 10 | Next 10 |
Teligent (NASDAQ: TLGT ): Q4 Non-GAAP EPS of -$0.17 misses by $0.15 ; GAAP EPS of -$0.10 misses by $0.01 . More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
BUENA, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth quarter and year ended December 31, 2019. Fourth Quarter 2019 Highlights Net Revenues for ...
BUENA, N.J., April 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00 a.m. ET on Wednesday, April 8, 2020 to discuss the 4 th quarter and 2019 full year financial result...
BUENA, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced a transition in leadership. Teligent has announced that Jason Grenfell-Gard...
BUENA, N.J., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its development partner has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its abbreviat...
BUENA, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies Global Healthcare Conference. The Conference is taking place November 20-21, 2019 in London, UK. Jason Grenfell-Gardn...
Teligent, Inc. (TLGT) Q3 2019 Earnings Conference Call November 4, 2019, 16:30 PM ET Company Participants Jason Grenfell-Gardner - President and CEO Damian Finio - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Scott Henry - ROTH Capital Elliot Wilbur...
Teligent (NASDAQ: TLGT ): Q3 Non-GAAP EPS of -$0.04 misses by $0.02 ; GAAP EPS of -$0.13 misses by $0.04 . More news on: Teligent, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
BUENA, N.J., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2019. Third Quarter 2019 Highlights Net revenues of $18.5 millio...
BUENA, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 4:30pm ET on Monday November 4 th , 2019 to discuss the 3 rd quarter 2019 financial results and business ...
News, Short Squeeze, Breakout and More Instantly...
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash collateral on a consensual basis Canadian entities to pursue sale process outside of Chap...
3 Penny Stocks to Watch With September Halfway Done With September already at the halfway point, there are plenty of penny stocks that investors are watching. And while it may seem easy at first to find valuable penny stocks to buy, it does take some time and a dedication to researc...
BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update. “Product demand in our core busin...